Advate is usually given every 8 to 24 hours for 1 to 4 days, depending on the reason you are using the medicine. This medicine comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.

How is Advate administered?

ADVATE should be administered via the intravenous route. In case of administration by a non-healthcare professional appropriate training is needed. The rate of administration should be determined to ensure the comfort of the patient up to a maximum of 10 ml/min.

How is Eloctate administered?

Perform intravenous bolus infusion. The rate of administration should be determined by the patient’s comfort level, and no faster than 10 ml per minute. After infusing ELOCTATE, remove and properly discard the infusion set.

How long does advate last?

ADVATE may be stored at room temperature (up to 30°C [86°F]) for a period of up to 6 months not to exceed the expiration date.

What is Advate used for?

ADVATE is a plasma/albumin-free recombinant factor VIII replacement therapy for patients with hemophilia A. ADVATE is indicated for prophylaxis, on-demand, and perioperative use in children and adults with hemophilia A and has an established safety profile.

What is the difference between advate and Adynovate?

The difference is that Adynovate is manufactured by attaching polyethylene glycol (PEG), a non-toxic and non-immunogenic polymer to Advate, allowing it to stay in the blood longer. By miming factor VIII, Adynovate allows blood clots to form, which stops the bleeding.

How do you infuse Alphanate?

Storing and infusing ALPHANATE Reconstituted ALPHANATE may be stored at room temperature (not to exceed 30°C) prior to administration, but administer intravenously within 3 hours. Discard any unused contents into an appropriate safety container. Do not administer ALPHANATE at a rate exceeding 10 mL/min.

Who manufactures advate?

Authorisation details

Publication details
Marketing-authorisation holderTakeda Manufacturing Austria AG
Revision27
Date of issue of marketing authorisation valid throughout the European Union02/03/2004
Contact addressIndustriestrasse 67 1221 Vienna Austria

What is Eloctate used for?

This medication is used to control and prevent bleeding that happens to people (usually males) with an inherited medical condition, hemophilia A (low levels of factor VIII). It is also given before surgery to prevent too much bleeding in people with this condition.

Is ADVATE a blood product?

In 2003, ADVATE became the first recombinant factor VIII treatment free of blood-based additives.

What company makes ADVATE?

Takeda has a variety of resources and programs to help you every step of the way with your treatment on ADVATE.

What is the difference between ADVATE and Adynovate?